Table: Aska Pharmaceutical Holdings -2021/22 group forecast

ASKA Pharmaceutical Holdings

20/12/2021 06:00

Dec 20 (Reuters) -
              Aska Pharmaceutical Holdings Co., Ltd.     
              CONSOLIDATED EARNINGS ESTIMATES
  (in billions of yen unless specified)                    
                 Full Year to      Full Year to 
               Mar 31, 2022      Mar 31, 2022   
                  LATEST           PREVIOUS     
                 FORECAST          FORECAST     
  Sales            55.00             54.50      
  Operating         3.50              3.50      
  Recurring         3.60              3.60      
  Net               3.00           loss 2.60    
  EPS           105.67 yen      loss 91.62 yen  
 
  NOTE - Aska Pharmaceutical Holdings Co., Ltd..    
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4886.T